Lymphangiogenesis and lymphatic vessel remodelling in cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nature Reviews. Cancer

• Publication date

  2014-02-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc3677PMID 24561443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.

  2013cited by this paper
• Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis

  2013cited by this paper
• Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature

  2013cited by this paper
• Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases.

  2013cited by this paper
• Inhibition of VEGF-C Modulates Distal Lymphatic Remodeling and Secondary Metastasis

  2013cited by this paper
• Monographs: The development of regorafenib and its current and potential future role in cancer therapy.

  2013cited by this paper
• Sunitinib malate for the treatment of pancreas malignancies – where does it fit?

  2013cited by this paper
• In vivo imaging of lymph node lymphangiogenesis by immuno-positron emission tomography.

  2013cited by this paper
• Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis.

  2013cited by this paper
• Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis

  2013cited by this paper
• Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses

  2013cited by this paper
• Pazopanib, a new therapy for metastatic soft tissue sarcoma

  2013cited by this paper
• Circulating Tumor Cell Enrichment Based on Physical Properties

  2013cited by this paper
• Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology

  2013cited by this paper
• Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism.

  2013cited by this paper
• Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery.

  2013cited by this paper
• Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis

  2013cited by this paper
• Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature

  2012cited by this paper
• Lymphatic endothelial cells - key players in regulation of tolerance and immunity

  2012cited by this paper
• Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.

  2012cited by this paper
• Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline

  2012cited by this paper
• Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis

  2012cited by this paper
• Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment

  2012cited by this paper
• Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

  2012cited by this paper
• Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor‐D

  2012cited by this paper
• Immunohistochemical Assessment of Lymphovascular Invasion in Stage I Colorectal Carcinoma: Prognostic Relevance and Correlation With Nodal Micrometastases

  2012cited by this paper
• Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator

  2012cited by this paper
• Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo[5,4-a]pyrrolo[3,4-c]

  2012cited by this paper
• Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung Metastasis

  2012cited by this paper
• VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium.

  2012cited by this paper
• The connection between lymphangiogenic signalling and prostaglandin biology: A missing link in the metastatic pathway

  2012cited by this paper
• Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline.

  2012cited by this paper
• Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.

  2012cited by this paper
• Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations.

  2012cited by this paper
• Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells

  2012cited by this paper
• VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.

  2012cited by this paper
• Lymphovascular Invasion in Non–Small-Cell Lung Cancer: Implications for Staging and Adjuvant Therapy

  2012cited by this paper
• Wnt1 is anti-lymphangiogenic in a melanoma mouse model.

  2012cited by this paper
• Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells.

  2012cited by this paper
• Deletion of Tetraspanin CD9 Diminishes Lymphangiogenesis in Vivo and in Vitro*

  2012cited by this paper
• Interaction of tumor cells and lymphatic vessels in cancer progression

  2012cited by this paper
• Experience with sorafenib in the treatment of advanced renal cell carcinoma

  2012cited by this paper
• Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity

  2012cited by this paper
• Inflammation-induced lymph node lymphangiogenesis is reversible.

  2012cited by this paper
• Lymphatic Invasion Is Independently Prognostic of Metastasis in Primary Cutaneous Melanoma

  2011cited by this paper
• Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer.

  2011cited by this paper
• Proteolytic processing of vascular endothelial growth factor‐D is essential for its capacity to promote the growth and spread of cancer

  2011cited by this paper
• Prognostic Significance of Lymphovascular Invasion for Patients with Stage I Non-Small Cell Lung Cancer

  2011cited by this paper
• Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis.

  2011cited by this paper
• Lymphatic vascular morphogenesis in development, physiology, and disease

  2011cited by this paper
• Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3

  2011cited by this paper
• Comparison of lymphangiogenesis between primary colorectal cancer and corresponding liver metastases.

  2011cited by this paper
• Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer.

  2011cited by this paper
• Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.

  2011cited by this paper
• VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling

  2011cited by this paper
• A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth.

  2011cited by this paper
• Roles of Prostaglandin E2–EP3/EP4 Receptor Signaling in the Enhancement of Lymphangiogenesis During Fibroblast Growth Factor-2–Induced Granulation Formation

  2011cited by this paper
• Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor.

  2011cited by this paper
• Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis.

  2011cited by this paper
• Developmental and pathological angiogenesis.

  2011cited by this paper
• Molecular control of endothelial cell behaviour during blood vessel morphogenesis

  2011cited by this paper
• The VD1 neutralizing antibody to vascular endothelial growth factor-D: binding epitope and relationship to receptor binding.

  2011cited by this paper
• The lymphatic vasculature in disease

  2011cited by this paper
• In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography.

  2010cited by this paper
• Neuropilin-2 mediates VEGF-C–induced lymphatic sprouting together with VEGFR3

  2010cited by this paper
• Erratum: ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21 (Cancer Research (2010) 70, (3239-3248) DOI:10.1158/0008-5472. CAN-09-3186)

  2010cited by this paper
• Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization.

  2010cited by this paper
• Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma

  2010cited by this paper
• AMG-386, a selective angiopoietin-1/-2-neutralizing peptibody for the potential treatment of cancer.

  2010cited by this paper
• Transmural Flow Modulates Cell and Fluid Transport Functions of Lymphatic Endothelium

  2010cited by this paper
• Prognostic Significance of Lymphovascular Invasion in Sporadic Colorectal Cancer

  2010cited by this paper
• Cancer dissemination--lessons from leukocytes.

  2010cited by this paper
• Lymphangiogenesis and lymphatic metastasis in breast cancer.

  2010cited by this paper
• Lymphangiogenesis: Molecular mechanisms and future promise.

  2010cited by this paper
• CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche.

  2010cited by this paper
• Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis.

  2010cited by this paper
• Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease.

  2009cited by this paper
• Alternatively spliced VEGF receptor-2 is an essential endogenous inhibitor of lymphatic vessels

  2009cited by this paper
• ccbe1 is required for embryonic lymphangiogenesis and venous sprouting

  2009cited by this paper
• Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis

  2009cited by this paper
• From tumor lymphangiogenesis to lymphvascular niche

  2009cited by this paper
• Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.

  2009cited by this paper
• VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab.

  2008cited by this paper
• Blocking neuropilin-2 function inhibits tumor cell metastasis.

  2008cited by this paper
• Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases

  2008cited by this paper
• Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis.

  2008cited by this paper
• Sialyl Lewis X Expression and Lymphatic Microvessel Density in Primary Tumors of Node-negative Colorectal Cancer Patients Predict Disease Recurrence

  2008cited by this paper
• Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer

  2008cited by this paper
• Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications

  2008cited by this paper
• A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis.

  2008cited by this paper
• CCR7 and its ligands: balancing immunity and tolerance

  2008cited by this paper
• Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

  2008cited by this paper
• Heterogeneity in Immunohistochemical, Genomic, and Biological Properties of Human Lymphatic Endothelial Cells Between Initial and Collecting Lymph Vessels

  2008cited by this paper
• Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis

  2007cited by this paper
• Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries

  2007cited by this paper
• Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling.

  2007cited by this paper
• Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer

  2007cited by this paper
• Lymphatic Microvessel Density is an Independent Prognostic Factor in Colorectal Cancer

  2007cited by this paper
• Proprotein convertases promote processing of VEGF‐D, a critical step for binding the angiogenic receptor VEGFR‐2

  2007cited by this paper
• Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting

  2007cited by this paper

• Insulin-like growth factor signaling regulates zebrafish lymphatic-vessel development.

  2026cites this paper
• Right patient approach to experimental stromal cell therapies for gastrointestinal tumors

  2026cites this paper
• Multiomic profiling of ER-positive HER2-negative breast cancer reveals markers associated with metastatic spread

  2026cites this paper
• Rapid and precise intraoperative identification of metastatic lymph nodes using a pH‑activated nanoprobe

  2026cites this paper
• Lactylation-drived TRIM29 induces invasive behavior and lymph node metastasis in gastric cancer via hnRNPA1-mediated Wnt/β-catenin pathway

  2026cites this paper
• Thrombospondin-4 drives lymphangiogenesis through cooperation with VEGF-C in human bladder cancer

  2026cites this paper
• Sentinel Lymph Node Biopsy in Melanoma: Overview and Updates

  2025cites this paper
• An LCN2‐Dependent Positive‐Feedback Loop Between Gastric Cancer Cells and Tumor‐Associated‐Macrophages Mediates Lymphangiogenesis and Lymphatic Metastasis

  2025cites this paper
• MRI Radiomics-Based Prediction of Occult Sentinel Lymph Node Metastasis and D2-40 Expression in Breast Cancer

  2025cites this paper
• Deep learning assisted non-invasive lymph node burden evaluation and CDK4/6i administration in luminal breast cancer

  2025cites this paper
• NCF2 drives tumor progression and metastasis through NR2F2/LATS2/YAP1 axis in esophageal squamous cell carcinoma.

  2025cites this paper
• Lymphovascular Invasion (LVI) Correlates with Systemic Immune-Inflammation Index (SII) in Adenocarcinoma of the Gastroesophageal Junction (AEG): Implications for Prognostic Stratification

  2025cites this paper
• Tertiary lymphoid structures are associated with lower axillary residual nodal burden in breast cancer patients after neoadjuvant chemotherapy

  2025cites this paper
• Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating VEGFA

  2025cites this paper
• Transcription factor A, mitochondrial promotes lymph node metastasis and lymphangiogenesis in epithelial ovarian carcinoma

  2025cites this paper
• Targeting glycolytic reprogramming by tsRNA-0032 for treating pathological lymphangiogenesis

  2025cites this paper
• The role of innate immune cells in modulating vascular dynamics in skin malignancies.

  2025cites this paper
• Effects of Thymidine Phosphorylase and Sine Oculis Homeobox Homologue 1 on the Prognosis and Immune Microenvironment of Gastric Cancer

  2025cites this paper
• Neutrophils in tumor- and inflammation-induced lymphangiogenesis

  2025influential citation
• A multistage drug delivery approach for colorectal primary tumors and lymph node metastases

  2025cites this paper
• MicroVasculoid‐Chip: A 3D Self‐Assembled Human Microcirculation‐on‐a‐Chip Model Reveals Enhanced Lymphangiogenic Lung Cancer‐Induced Vessel Remodeling and Invasion

  2025cites this paper
• Understanding the Lymphatic System: Tissue-on-Chip Modeling.

  2025cites this paper
• Lung cancer-associated fibroblasts-mediated collagen deposition drives mediastinal lymph node metastasis in non-small cell lung cancer

  2025cites this paper
• Molecular Mechanisms of Lymphatic Metastasis in Breast Cancer: An Updated Review

  2025cites this paper
• Utility of an in vitro lymphatics on-chip model for rank ordering subcutaneous absorption of monoclonal antibodies.

  2025cites this paper
• Limited Proteolysis as a Regulator of Lymphatic Vessel Function and Architecture

  2025cites this paper
• Ang-2 modulates VEGFR3-induced lymphangiogenesis in peritumoral adipose tissue of metastatic head and neck cancer

  2025cites this paper
• Rewiring the Lymphatic Landscape: Disorders, Remodeling, and Cancer Progression

  2025cites this paper
• Focal adhesion kinase/Src family kinase axis-mediated tyrosine phosphorylation of metabolic enzymes facilitates tumor metastasis

  2025cites this paper
• CCR10: a comprehensive review of its function, phylogeny, role in immune cell trafficking and disease pathogenesis

  2025cites this paper
• SOAT1 Activates NLRP3 Inflammasome to Promote Cancer‐Related Lymphangiogenesis and Metastasis via IL‐1β/IL‐1R‐1 Axis in Oral Squamous Cell Carcinoma

  2025cites this paper
• Lymphatic Endothelial Cells and Organ-Associated Lymphangiogenesis in Tumor Microenvironment

  2025cites this paper
• Elevated CD36 drives lymph node metastasis of breast cancer by activating Hippo-YAP signaling-mediated anoikis resistance

  2025cites this paper
• Unraveling the impact of cancer-associated fibroblasts on lymphatic metastasis of head and neck squamous cell carcinoma

  2025cites this paper
• Lymphatic vessel network injury reduces local tumor control despite preservation of the tumor-draining lymph node

  2025cites this paper
• Transporting via Neutrophil as a Key Mechanism for Nanoparticle Redistribution to Tumor and Spleen.

  2025cites this paper
• Lymphangiogenesis in Breast Cancer: From Molecular Mechanisms to Clinical Implications

  2025cites this paper
• Urolithin A-Laden Functional Nanoparticles alleviate Cisplatin-Induced Cardiotoxicity in mice by inhibiting Inflammation-Induced Lymphangiogenesis.

  2025cites this paper
• Natural medicines target tumor vascular microenvironment to inhibit tumor

  2025cites this paper
• AXL promotes lymphangiogenesis by amplifying VEGF-C-mediated AKT pathway

  2025cites this paper
• SORBS3-β suppresses lymph node metastasis in cervical cancer by promoting the ubiquitination of β-catenin

  2025cites this paper
• Exploring the therapeutic potential of Danggui Shaoyao San in nephrotic syndrome: Impact on skin sodium content and renal function

  2025cites this paper
• Lymphatic transport in anti-tumor immunity and metastasis.

  2025cites this paper
• Lymphangiogenesis orchestrating tumor microenvironment: Face changing in immunotherapy.

  2025cites this paper
• Lymphangiogenesis in mouse embryonic and early postnatal ovaries.

  2025cites this paper
• Bispecific receptor decoy proteins inhibit ocular neovascularization via simultaneous blockade of vascular endothelial growth factor A and C.

  2025cites this paper
• Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma

  2025cites this paper
• Podoplanin - Related Lymphatic Micro Vessel Density Digital Analysis in Breast Adenocarcinoma

  2025cites this paper
• NNMT-mediated N6-methyladenosine modification of NR4A3 mRNA facilitates lymphatic metastasis of gastric adenocarcinoma

  2025cites this paper
• “Unraveling EMILIN-1: A Multifunctional ECM Protein with Tumor-Suppressive Roles” Mechanistic Insights into Cancer Protection Through Signaling Modulation and Lymphangiogenesis Control

  2025cites this paper
• LINC01116, a hypoxia-lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma.

  2025cites this paper
• Personalized 3D Vaccine Integrates Immunotherapy and Antiangiogenic Therapy to Prevent Oral Squamous Cell Carcinoma Recurrence

  2025cites this paper
• Discovery of Abundant Nano-scale Lymphatic-like Vessels in Brains

  2025cites this paper
• PD-L1 expression in microvascular endothelial cells predicts the efficacy and side effects of anlotinib

  2025cites this paper
• Pipelines for lymphocyte homeostasis maintenance during cancer immunotherapy

  2025cites this paper
• Evaluation of prognostic value of vascular endothelial growth factor and endocan in non-small cell lung cancer

  2025cites this paper
• LAMP1 enhances DNA-PKcs-mediated AKT phosphorylation and VEGFC secretion to promote lymph node metastasis in esophageal squamous cell carcinoma

  2025cites this paper
• Potentiating immunotherapy in “immune-cold” solid tumors through orchestrating T cell immunity via tumor-specific genetic engineering

  2025cites this paper
• Deep learning-based pathological prediction of lymph node metastasis for patient with renal cell carcinoma from primary whole slide images

  2024cites this paper
• Data‐Driven Design of Triple‐Targeted Protein Nanoprobes for Multiplexed Imaging of Cancer Lymphatic Metastasis

  2024cites this paper
• TMVP1448, a novel peptide improves detection of primary tumors and metastases by specifically targeting VEGFR-3.

  2024cites this paper
• An arabinogalactan isolated from Cynanchum atratum promotes lymphangiogenesis and lymphatic vessel remodeling to alleviate secondary lymphedema.

  2024cites this paper
• Expression of Truncated Products at the 5′-Terminal Region of RIPK2 and Evolutive Aspects that Support Their Biological Importance

  2024cites this paper
• The role of lymphatic endothelial cell metabolism in lymphangiogenesis and disease

  2024cites this paper
• A Novel Ex Vivo Tumor Spheroid-Tissue Model for Investigating Microvascular Remodeling and Lymphatic Blood Vessel Plasticity

  2024cites this paper
• MicroRNA‐431‐5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF‐β1/SMAD2/3 signaling via ZEB1 in gastric cancer

  2024cites this paper
• The promotion of non‐small cell lung cancer progression by collagen and calcium binding EGF domain 1 is mediated through the regulation of ERK/JNK/P38 phosphorylation by reactive oxygen species

  2024cites this paper
• Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer.

  2024cites this paper
• Cancer metastasis through the lymphatic versus blood vessels

  2024cites this paper
• Role of the Lymphatics in Cardiac Disease.

  2024cites this paper
• Role of imbalanced gut microbiota in promoting CRC metastasis: from theory to clinical application

  2024cites this paper
• A case for the study of native extracellular vesicles

  2024cites this paper
• Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression

  2024cites this paper
• The global landscape and research trend of lymphangiogenesis in breast cancer: a bibliometric analysis and visualization

  2024cites this paper
• Acid‐sensing receptor GPR4 plays a crucial role in lymphatic cancer metastasis

  2024cites this paper
• Linagliptin's impact on lymphatic barrier and lymphangiogenesis in oral cancer with high glucose.

  2024cites this paper
• Unraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1

  2024influential citation
• Molecular biology of targeting lymphangiogenesis in cancer: therapeutic strategies and future promise

  2024cites this paper
• Prognostic Significance of Plasma VEGFA and VEGFR2 in Acute Ischemic Stroke-a Prospective Cohort Study

  2024cites this paper
• State-of-the-art drug delivery system to target the lymphatics

  2024cites this paper
• The Tumor Immune Microenvironment plays a Key Role in Driving the Progression of CholangioCarcinoma.

  2024cites this paper
• Quantitative multiplex immunohistochemistry reveals inter-patient lymphovascular and immune heterogeneity in primary cutaneous melanoma

  2024cites this paper
• EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and cisplatin resistance

  2024cites this paper
• Phenotypic Heterogeneity, Bidirectionality, Universal Cues, Plasticity, Mechanics, and the Tumor Microenvironment Drive Cancer Metastasis

  2024cites this paper
• Revealing neuropilin expression patterns in pancreatic cancer: From single‑cell to therapeutic opportunities (Review)

  2024cites this paper
• The Arteria Lymphatica and Lymphatic Microperforators: A Dedicated Blood Supply to Collecting Lymphatics and Their Potential Implications in Lymphedema: Anatomical Description

  2024cites this paper
• DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/AKT axis and VEGF-C secretion.

  2024cites this paper
• When Lymphatics, the Devil and Maleficent Melanoma meet

  2024cites this paper
• Engineering Lymphangiogenesis‐On‐Chip: The Independent and Cooperative Regulation by Biochemical Factors, Gradients, and Interstitial Fluid Flow

  2024cites this paper
• NAT10‐mediated ac4C‐modified ANKZF1 promotes tumor progression and lymphangiogenesis in clear‐cell renal cell carcinoma by attenuating YWHAE‐driven cytoplasmic retention of YAP1

  2024cites this paper
• Lymphatic vessels in the age of cancer immunotherapy

  2024cites this paper
• Angiogenesis, a key point in the association of gut microbiota and its metabolites with disease

  2024cites this paper
• Molecular Characterization and Interaction between Human VEGF-D and VEGFR-3

  2024cites this paper
• Vaping and tumor metastasis: current insights and progress

  2024cites this paper
• Biomechanical research using advanced micro-nano devices: In-Vitro cell Characterization focus

  2024cites this paper
• The role of ferroptosis resistance in lymph-associated tumour metastasis.

  2024cites this paper
• Empagliflozin attenuating renal interstitial fibrosis in diabetic kidney disease by inhibiting lymphangiogenesis and lymphatic endothelial-to-mesenchymal transition via the VEGF-C/VEGFR3 pathway.

  2024cites this paper
• Delivery of imiquimod to intestinal lymph nodes following oral administration.

  2024cites this paper
• Cancer-induced systemic pre-conditioning of distant organs: building a niche for metastatic cells

  2024cites this paper
• Activating Invasion and Metastasis in Small Cell Lung Cancer: Role of the Tumour Immune Microenvironment and Mechanisms of Vasculogenesis, Epithelial‐Mesenchymal Transition, Cell Migration, and Organ Tropism

  2024cites this paper